Decrease of Interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer
Open Access
- 1 May 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (5) , 457-461
- https://doi.org/10.1023/a:1008242000431
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Selective suppression of cytokine secretion in patients with small-cell lung cancerAnnals of Oncology, 1995
- Does TGF β1 Play a Role in Immunosuppression in Small-Cell Lung Cancer?Published by S. Karger AG ,1995
- Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell linesEuropean Journal Of Cancer, 1994
- Small-cell carcinoma of the lung: derivation of a prognostic staging system.Journal of Clinical Oncology, 1991
- Evaluation of a test system for measuring cytokine production in human whole blood cell culturesJournal of Immunological Methods, 1991
- Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.Journal of Clinical Oncology, 1990
- Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?British Journal of Cancer, 1990
- SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCERThe Lancet, 1982
- A whole-blood technique for testing production of human interferon by leukocytesJournal of Immunological Methods, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958